MT1 melatonin receptor expression in Warthin's tumor

Area of Science:

• Oncology
• Endocrinology
• Histopathology

Background:

• Warthin's tumor is a benign salivary gland neoplasm.
• The MT1 melatonin receptor plays a role in various cellular processes.
• Limited data exists on MT1 receptor expression in Warthin's tumor.

Purpose of the Study:

• To perform the first immunohistochemical analysis of the MT1 melatonin receptor in Warthin's tumor.
• To compare MT1 receptor expression in Warthin's tumor with normal parotid gland tissue.
• To evaluate the potential of Warthin's tumor as a positive control for MT1 receptor immunohistochemistry.

Main Methods:

• Immunohistochemistry was used to detect MT1 melatonin receptor expression.
• Samples included 14 Warthin's tumors and adjacent normal parotid gland tissue.
• Staining intensity and localization were analyzed in epithelial and lymphoid components.

Main Results:

• Intense cytoplasmic positivity for MT1 receptor was observed in epithelial cells lining spaces in all Warthin's tumors.
• Basal cells in Warthin's tumors showed less intense MT1 receptor positivity.
• The lymphoid component of Warthin's tumors was consistently negative for MT1 receptor.
• Normal parotid gland excretory ducts showed intense MT1 receptor positivity, while acinar cells had focal positivity.
• MT1 receptor expression in parotid ductal epithelium may mirror its activity in Warthin's tumor cells.

Conclusions:

• Warthin's tumor demonstrates significant MT1 melatonin receptor expression.
• The expression pattern in Warthin's tumor resembles that of normal parotid excretory duct epithelium.
• Warthin's tumor is proposed as a valuable positive control for MT1 melatonin receptor immunohistochemical studies.